Oppenheimer Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,507
| Closed | -$458K | – | 1189 |
|
|
2023
Q3 | $458K | Buy |
10,507
+2,297
| +28% | +$100K | 0.01% | 869 |
|
|
2023
Q2 | $297K | Sell |
8,210
-497
| -6% | -$18K | ﹤0.01% | 973 |
|
|
2023
Q1 | $324K | Buy |
8,707
+1,456
| +20% | +$54.1K | 0.01% | 951 |
|
|
2022
Q4 | $329K | Sell |
7,251
-349
| -5% | -$15.8K | 0.01% | 946 |
|
|
2022
Q3 | $531K | Sell |
7,600
-209
| -3% | -$14.6K | 0.01% | 818 |
|
|
2022
Q2 | $524K | Buy |
7,809
+3,859
| +98% | +$259K | 0.01% | 842 |
|
|
2022
Q1 | $325K | Buy |
+3,950
| New | +$325K | ﹤0.01% | 1016 |
|